---
$id: https://graph.org.ai/products/commodity/51162624
$type: Product
source: UNSPSC
code: "51162624"
title: "Dimemorfan"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dimemorfan

**UNSPSC Code**: 51162624
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent and anticonvulsant agent with the molecular formula C18H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 623OAC38YU, chemically known as morphinan, 3,17-dimethyl-, (9alpha,13alpha,14alpha)- but more generally known as dimemorfan, which bears US NIH Compound Identifier 3037918. European Medicines Agency schedules Dimemorfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07158MIG. The term DIMEMORFAN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21, No. 3, 2007, List 58). World Health Organization schedules dimemorfan in its Anatomical Therapeutic Chemical (ATC) Classification. DIMEMORFAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule dimemorfan under HS 29334990 and SITC 51575. As of Q4 2014, DIMEMORFAN remains US FDA's Preferred Term for this commodity. Dimemorfan bears US NLM identifiers UMLS ID C0058193 and NCI Concept Code C65399. SMILES: N1(C2C3C(CC1)(CCCC3)C1C(C2)CCC(C1)C)C.

